TITLE

Sequenom opens Eastern ops

PUB. DATE
December 1998
SOURCE
Chemical Market Reporter;12/28/98, Vol. 254 Issue 26, p33
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on Sequenom Inc.'s expansion into the genomic products market in the East Coast, with the opening of its office in Boston, Massachusetts.
ACCESSION #
1418269

 

Related Articles

  • Agreements roundup.  // Medical Device Daily;1/14/2008, Vol. 12 Issue 9, p4 

    This article states that MetaMorphix has forged a partnership with Sequenom in which MetaMorphix will adopt Sequenom's MassArray and iPLEX foundation technologies. It explains that iPLEX provides cost-effective genotyping and enhanced efficiencies. MetaMorphix will be able to scale up fast its...

  • Antioxidant Shows Promise for Hearing Loss. Webb, Marion // San Diego Business Journal;3/10/2003, Vol. 24 Issue 10, p8 

    Reports on news and developments related to the biotechnology industry in San Diego, California as of March10, 2003. Results of a test conducted by American BioHealth Group LLC and the U.S. Navy for an antioxidant to prevent hearing damage or loss; Financial losses incurred by Sequenom Inc. for...

  • Struggling Biotech Mulls Closing Up Shop. Webb, Marion // San Diego Business Journal;5/10/2004, Vol. 25 Issue 19, p9 

    Reports on news and developments concerning the biotechnology industry in San Diego, California, as of May 10, 2004. FeRx Inc.'s decision to stop testing its flagship product, a technology to pull anti-cancer drugs to specific cancer sites; First quarter earnings of Sequenom Inc.; Resignation of...

  • BIOTECH. Webb, Marion // San Diego Business Journal;6/6/2005, Vol. 26 Issue 23, p11 

    Reports on developments relevant to the biotechnology industry of San Diego, California, as of June 6, 2005. Sequenom Inc.; La Jolla Pharmaceutical Co.; Adventrx Pharmaceuticals Inc.

  • Biotechnology Picks Up Speed On a Wave of Recent IPO Filings. Papanikolaw, Jim // Chemical Market Reporter;02/07/2000, Vol. 257 Issue 6, p11 

    Focuses on initial public offerings at biotechnology industry in the United States. Details on the public offering of Sequenom Inc.; Information on InterMune company; Other therapies to be developed by DrugAbuse company.

  • Sequenom's Struggles Lead to Layoffs. Webb, Marion // San Diego Business Journal;8/9/2004, Vol. 25 Issue 32, p9 

    Reports developments on the biotechnology industry in San Diego, California as of August 2004. Plans of Sequenom Inc. to layoff some employees, terminate its drug discovery efforts and close its pharmaceuticals business unit; Focus of the company on selling its gene-screening technology to...

  • CLINIC ROUNDUP.  // BioWorld Today;5/13/2009, Vol. 20 Issue 91, p2 

    This section offers news briefs concerning the biotechnology sector as of May 2009. Positive results has been announced by DARA BioSciences Inc. from a Phase IIa trial of KRN5500 for treatment of neuropathic pain in patients with advanced cancer. Oncolytics Biotech Inc. has successfully...

  • Genomics News Headlines June 15, 2003 - July 14, 2003.  // PharmaWatch: Biotechnology;August 2003, Vol. 2 Issue 8, p32 

    Reports on global developments related to the pharmaceutical biotechnology industry from June 15 to July 14, 2004. Identification of a clotting protein which causes hepatitis B; Investment made by Great Britain for genetic research; Collaboration between Sequenom Inc. and Bristol-Myers Squibb Co.

  • Sequenom and Bristol-Myers Squibb enter genomic collaboration.  // PharmaWatch: Biotechnology;August 2003, Vol. 2 Issue 8, p36 

    Reports on the collaboration between Sequenom Inc. and Bristol-Myers Squibb Co. in the U.S. Terms under the collaboration; Benefits of the collaboration for parties involved; Significance of the collaboration for the biotechnology industry.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics